Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients

Use of recombinant human erythropoietin (rh-Epo) improves hemoglobin (Hgb) in 90-95% of the cases of anemia of chronic kidney disease (CKD). However, it is known that pro-inflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alfa (TNF-α) and interleukin-1 (IL-1) suppress ery...

Full description

Bibliographic Details
Main Authors: Amir-Hooshang Mohammadpour, Fatemeh Nazemian, Mohammad Hassanzade Khaiat, Mohsen Tafaghodi, Pooneh Salari, Somaieh Charkazi, Masih Naghibi, Jamal Shamsara
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2014;volume=25;issue=1;spage=73;epage=78;aulast=Mohammadpour

Similar Items